Two separate class action lawsuit file ICN Pharmaceuticals Inc Viratek Inc VIRA> subsidiary charge company disseminate allegedly false mislead information regard company's drug Virazole test treatment AIDS. The suit file Federal Court behalf ICN shareholder charge disclosure ICN past encourage invest believe Virazole promising drug major importance disclose serious adverse effect court document said. An ICN spokesman decline comment lawsuits. Attorneys plaintiff immediately available comment. Virazole know ribavirin undergo extensive test treatment AIDS-related illnesses. The drug available country outside United States approve FDA domestically aerosol form treatment infection strike child call respiratory syncytial virus. The FDA subcommittee conduct separate probe whether ICN withheld data FDA adverse reaction antiviral drug. The Securities Exchange Commission investigate company. Reuter 